Dermatology

A Wealth of Experience

We have collaborated with our clients on projects to research cutaneous diseases, cutaneous treatment, and complications and comorbidities of cutaneous disease.  Our experience includes:  

  • Acne
  • Alopecia
  • Atopic dermatitis
  • Dry skin
  • Eczema
  • Herpes
  • Psoriasis
  • Skin cancer
    • Basal cell carcinoma
    • Squamous cell carcinoma
    • Melanoma
  • Stevens-Johnson syndrome
  • Systemic lupus erythematosus
  • Toxic epidermal necrolysis
  • Warts

Types of Projects

We have implemented studies to help our clients develop strategies in the dermatology market and to develop and gain 
market access for products to treat cutaneous diseases and complications arising from treatment of cutaneous illnesses. 

Recent projects have included:

Our Experts

Chris Knight
Senior Director, Health Economics
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Ari Gnanasakthy
Principal Scientist, Patient-Centered Outcomes Assessment
William L Herring
Senior Director, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Xiaolei Zhou
Director, Biostatistics
Bintu Sherif
Director, Biostatistics
Caroline Ling
Senior Director and HTA Specialist, Market Access and Outcomes Strategy
Daniel Mines
Senior Director, Epidemiology
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Katherine Stull
Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Lauren Nelson
Senior Director, Psychometrics, Patient-Centered Outcomes Assessment
Diane Whalley
Executive Director, Patient-Centered Outcomes Assessment
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Dee Dee Mladsi (she/her)
Head, Health Economics—Strategy and Early Modeling
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Kelly Hollis
Vice President, Surveys and Observational Studies
Mark Price
Senior Director, Health Economics
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Patricia Sacco
Executive Director, Surveys and Observational Studies
Dawn Odom
Vice President, Biostatistics
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
T. Michelle Brown
Senior Director, Patient-Centered Outcomes Assessment
James Twiss
Senior Research Scientist, Patient-Centered Outcomes Assessment
Marci Clark
Director, Patient-Centered Outcomes Assessment
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Mary Anthony
Senior Director, Epidemiology
Josephine Mauskopf
Vice President, Health Economics
Elena Rivero
Senior Director, Epidemiology
Margaret Mordin
Executive Director, Market Access and Outcomes Strategy

Selected Recent Dermatology Publications

Arana A, Pottegard A, Kuiper JG, Crellin E, Reutfors J, Schmitt-Egenolf M, Lund LC, Houben E, Booth H, Calingaert B, Kaye JA, Gembert K, Rothman KJ, Dedman D, Kieler H, Gutierrez L, Hallas J, Perez-Gutthann S. To what extent are topical tacrolimus or pimecrolimus associated with an increased risk of skin cancer and lymphoma? Long-term results from JOELLE study. Poster to be given at the 2020 Virtual European Academy of Dermatology and Venereology Conference; October 29, 2020. Previously presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Arana A, Pottegard A, Kuiper JG, Crellin E, Reutfors J, Schmitt-Egenolf M, Lund LC, Houben E, Booth H, Calingaert B, Kaye JA, Gembert K, Rothman KJ, Dedman D, Kieler H, Gutierrez L, Hallas J, Perez-Gutthann S. To what extent are topical tacrolimus or pimecrolimus associated with increased risk of skin cancer and lymphoma? Long-term results from Joelle Study. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.